Literature DB >> 18410700

The relationship of dementia prevalence in older adults with intellectual disability (ID) to age and severity of ID.

A Strydom1, A Hassiotis, M King, G Livingston.   

Abstract

BACKGROUND: Previous research has shown that adults with intellectual disability (ID) may be more at risk of developing dementia in old age than expected. However, the effect of age and ID severity on dementia prevalence rates has never been reported. We investigated the predictions that older adults with ID should have high prevalence rates of dementia that differ between ID severity groups and that the age-associated risk should be shifted to a younger age relative to the general population.
METHOD: A two-staged epidemiological survey of 281 adults with ID without Down syndrome (DS) aged 60 years; participants who screened positive with a memory task, informant-reported change in function or with the Dementia Questionnaire for Persons with Mental Retardation (DMR) underwent a detailed assessment. Diagnoses were made by psychiatrists according to international criteria. Prevalence rates were compared with UK prevalence and European consensus rates using standardized morbidity ratios (SMRs).
RESULTS: Dementia was more common in this population (prevalence of 18.3%, SMR 2.77 in those aged 65 years). Prevalence rates did not differ between mild, moderate and severe ID groups. Age was a strong risk factor and was not influenced by sex or ID severity. As predicted, SMRs were higher for younger age groups compared to older age groups, indicating a relative shift in age-associated risk.
CONCLUSIONS: Criteria-defined dementia is 2-3 times more common in the ID population, with a shift in risk to younger age groups compared to the general population.

Entities:  

Mesh:

Year:  2008        PMID: 18410700     DOI: 10.1017/S0033291708003334

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  16 in total

1.  Developmental level and other factors associated with symptoms of mental disorders and problem behaviour in adults with intellectual disabilities living in the community.

Authors:  Oddbjørn Hove; Odd E Havik
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-04-05       Impact factor: 4.328

2.  Rapid assessment of cognitive function in down syndrome across intellectual level and dementia status.

Authors:  D M Walsh; E Doran; W Silverman; A Tournay; N Movsesyan; I T Lott
Journal:  J Intellect Disabil Res       Date:  2015-05-29

3.  Down syndrome and dementia: seizures and cognitive decline.

Authors:  Ira T Lott; Eric Doran; Vinh Q Nguyen; Anne Tournay; Nina Movsesyan; Daniel L Gillen
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  Implementation challenges in end-of-life research with adults with intellectual and developmental disabilities.

Authors:  Teresa A Savage; Teresa Thalia Moro; Jackelyn Y Boyden; Allison A Brown; Karen L Kavanaugh
Journal:  Appl Nurs Res       Date:  2014-10-13       Impact factor: 2.257

5.  Intellectual Disability, Mild Cognitive Impairment, and Risk for Dementia.

Authors:  Wayne P Silverman; Warren B Zigman; Sharon J Krinsky-McHale; Robert Ryan; Nicole Schupf
Journal:  J Policy Pract Intellect Disabil       Date:  2013-09-01

Review 6.  Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome.

Authors:  Panagiotis Zis; Andre Strydom
Journal:  Free Radic Biol Med       Date:  2017-09-01       Impact factor: 7.376

7.  Prevalence of Depression and Dementia among Adults with Developmental Disabilities in Manitoba, Canada.

Authors:  Shahin Shooshtari; Patricia Joan Martens; Charles A Burchill; Natalia Dik; Saba Naghipur
Journal:  Int J Family Med       Date:  2011-08-08

Review 8.  Health promotion and disease prevention strategies in older adults with intellectual and developmental disabilities.

Authors:  Eli Carmeli; Bita Imam
Journal:  Front Public Health       Date:  2014-04-14

9.  Gender differences in psychiatric diagnoses in older people with intellectual disability: a register study.

Authors:  Anna Axmon; Magnus Sandberg; Gerd Ahlström
Journal:  BMC Psychiatry       Date:  2017-05-22       Impact factor: 3.630

10.  Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome.

Authors:  Andre Strydom; Amanda Heslegrave; Carla M Startin; Kin Y Mok; John Hardy; Jurgen Groet; Dean Nizetic; Henrik Zetterberg
Journal:  Alzheimers Res Ther       Date:  2018-04-10       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.